Dr. Stephen Hahn, 24th US FDA Commissioner And Former Chief Medical Executive At MD Anderson, Joins Flagship Pioneering As Chief Medical Officer Of Flagship's Preemptive Medicine And Health Security Initiative
CAMBRIDGE, Mass., June 14, 2021 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Stephen Hahn, M.D. will help lead its Preemptive Medicine and Health Security initiative as Chief Medical Officer, and join Flagship's Senior Leadership Team, effective June 16, 2021. Dr. Hahn served as the U.S. Food and Drug Administration Commissioner from 2019-2021. Prior to joining the FDA, he was the Chief Medical Executive, The University of Texas MD Anderson Cancer Center.